Eltrombopag
FDA Approved: * January 17, 2025Pharm Company: * HETERO LABS LTD V
Category: Blood Clotting (Hemostasis)
Eltrombopag, sold under the brand name Promacta among others, is a medication used to treat thrombocytopenia (abnormally low platelet counts) and severe aplastic anemia. Promacta (eltrombopag) is known as Revolade® outside the U.S. and is marketed worldwide by Novartis.[5] It is a thrombopoietin receptor agonist.[3] Eltrombopag was discovered as a result of research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals and is transferred to Nova... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Dosage List
Eltrombopag 12.5 mg Oral Powder, for Suspension
NDC: 31722-300
Labeler:
Camber Pharmaceuticals, Inc.
Popular Topics
Eltrombopag and amphetamines
Would like to know what happens if takentogether...